Bioteque financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
NT$347.43M NT$402.36M NT$491.85M NT$560.06M NT$654.86M NT$780.01M NT$821.62M NT$760.31M NT$842.31M NT$957.88M NT$1.12B NT$1.26B NT$1.41B NT$1.42B NT$1.61B NT$1.86B NT$1.95B NT$1.83B NT$2.01B NT$1.94B NT$0.00M
GM % Gross Margin %
21.82% 25.22% 26.39% 25.83% 30.66% 35.83% 37.61% 31.62% 34.92% 40.30% 42.29% 43.73% 44.49% 42.51% 42.72% 43.95% 43.73% 43.98% 42.01% 42.11% 0.00%
OM Operating Margin
4.35% 7.18% 10.07% 9.03% 14.07% 19.92% 21.25% 13.92% 18.43% 24.69% 26.55% 29.24% 31.18% 30.15% 30.33% 31.23% 31.15% 30.02% 28.77% 29.83% 0.00%
EPS Earnings Per Share
NT$2.74 NT$3.33 NT$4.17 NT$4.03 NT$5.14 NT$4.37 NT$5.81 NT$6.67 NT$7.02 NT$6.20 NT$7.09 NT$6.50 NT$0.00
Div. Dividends
NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$2.25 NT$2.62 NT$2.60 NT$3.00 NT$3.50 NT$4.00 NT$4.00 NT$4.00 NT$0.00 NT$4.50 NT$0.00 NT$0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 67.57% 62.83% 64.52% 58.37% 80.09% 68.85% 59.97% 56.98% 0 63.47% 0 0
Sha. Shares
45.24m 49.54m 49.87m 62.53m 62.68m 62.68m 62.68m 62.68m 62.68m 67.08m 68.37m 68.82m 69.3m 69.3m 69.3m 69.3m 69.3m 69.3m 69.3m 0m 69.3m
OCF Operating Cash Flow
NT$69.44M NT$84.39M NT$77.47M NT$159.77M NT$277.23M NT$174.32M NT$185.39M NT$148.43M NT$186.92M NT$270.44M NT$368.71M NT$385.43M NT$380.63M NT$336.51M NT$460.41M NT$623.41M NT$634.51M NT$469.25M NT$644.58M NT$679.38M NT$0.00M
FCF Free Cash Flow
NT$38.37M NT$-122.49M NT$14.11M NT$48.41M NT$-4.44M NT$25.36M NT$153.39M NT$108.13M NT$162.43M NT$177.72M NT$96.24M NT$299.61M NT$243.78M NT$273.54M NT$349.13M NT$484.02M NT$462.72M NT$-81.63M NT$-82.25M NT$606.62M NT$0.00M
FCFS Free Cash Flow Per Share
NT$0.85 NT$-2.49 NT$0.28 NT$0.82 NT$-0.07 NT$0.40 NT$2.45 NT$1.73 NT$2.59 NT$2.39 NT$1.42 NT$3.86 NT$3.52 NT$3.94 NT$5.04 NT$6.98 NT$6.68 NT$-1.18 NT$-1.19 NT$8.75 NT$0.00